Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Chiappella, Annalisa  [Clear All Filters]
2024
Chiappella A, Casadei B, Chiusolo P, Di Rocco A, Ljevar S, Magni M, Angelillo P, Barbui AMaria, Cutini I, Dodero A, et al. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia. 2024.
2023
Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai SVeronica, Castellino C, Stefoni V, Pinto A, Zanni M, et al. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. Leukemia. 2023.
2022
Rusconi C, Cheah CY, Eyre TAndrew, Tucker DL, Klener P, Giné E, Crucitti L, Muzi C, Iadecola S, Infante G, et al. Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse. Blood. 2022.
Vegliante MCarmela, Mazzara S, Zaccaria GMaria, De Summa S, Esposito F, Melle F, Motta G, Sapienza MRosaria, Opinto G, Volpe G, et al. NR1H3 (LXRα) IS ASSOCIATED WITH PRO-INFLAMMATORY MACROPHAGES, PREDICTS SURVIVAL AND SUGGESTS POTENTIAL THERAPEUTIC RATIONALES IN DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol. 2022.
2021
Chiappella A, Ladetto M. The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma. Lancet Haematol. 2021;8(9):e617-e619.
2020
Chiappella A, Corradini P. Selective inhibitors of nuclear export in aggressive B-cell lymphomas. Lancet Haematol. 2020;7(7):e500-e501.